Skip to main content

Table 2 p-values and relationship between vitronectin and nuclei morphometric measurements and poor prognostic factors

From: Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma

Parameter

Age: ā‰„18ā€‰months

Stage: M

Hist.D: uNB/pdNB

MYCN: MNA

Gen. profile: SCA

11q: 11qD

Risk group: high-risk

Gen. Instab.:High

IPP

Nuclei

Dens.

ā€“

0.005ā†‘

0.007ā†‘

0.001ā†‘

ā€“

ā€“

0.001ā†‘

0.003ā†‘

%SA

0.004ā†‘

ā€“

ā€“

ā€“

0.018ā†“

ā€“

ā€“

ā€“

Inter.VN

%SA

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

Terr.VN

%SA

ā€“

0.010ā†‘

0.001ā†‘*

0.024ā†‘

0.001ā†‘

0.035ā†‘

0.008ā†‘

0.000ā†‘

Densito

VN ratio of pixels

Weak

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

Mod.

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

ā€“

Strong

ā€“

0.037ā†‘

0.010ā†‘*

0.011ā†‘

0.002ā†‘

0.021ā†‘

0.004ā†‘

0.010 ā†‘

H-score

ā€“

ā€“

0.019ā†‘

0.040ā†‘

0.011ā†‘

ā€“

0.008ā†‘

0.001ā†‘

  1. Only morphometric variables for vitronectin (VN) expression and nuclei having a statistically significant relationship with pre-treatment risk stratification factors are shown (p-value<ā€‰0.05). IPP: Image Pro-Plus; Densito: DensitoQuant; Dens. Density (number of objects/mm2); %SA: percentage of stained area; Inter. VN: Interterritorial VN; Terr.VN: Territorial VN; Mod.: moderate. M: metastatic; Hist.D: histopathologic differentiation; uNB: undifferentiated neuroblastoma; pdNB: poorly differentiated neuroblastoma; NOS was excluded from statistical analysis; Gen. Profile: genetic profile; SCA: segmental chromosomal aberration; MNA: MYCN amplified; 11qD: 11q deletion; Gen. Instab.: genetic instability. -: not statistically significant, ā†‘/ā†“: higher or lower median value for the poor-prognostic group(s). *There are statistically significant differences between pdNB and uNB, within Strong VN (p-value<ā€‰0.05) and %SA Territorial VN (p-value<ā€‰0.1) morphometric variables